title: Relationship between hepatic angiotensinogen mRNA expression and plasma angiotensinogen in patients with chronic hepatitis.
abstract: Recent association and linkage studies suggested that angiotensinogen may play an important role in the pathogenasis of essential hypertension. However, there is little information in human concerning a relationship between plasma angiotensinogen levels and the angiotensinogen mRNA expression in the liver, which is the main production site of angiotensinogen. Therefore, the aim of this study was to examine whether hepatic angiotensinogen gene expression determines the level of circulating angiotensinogen and the activity of the renin-angiotensin system in humans. The subjects were 36 patients with chronic hepatitis. Blood was collected from each patients for estimation of plasma renin activity, plasma angiotensinogen and angiotensin II concentrations and several parameters of liver function. In addition, total RNA was isolated from liver biopsy specimens, which were then used to measure angiotensinogen mRNA with Northern blot analysis. Levels of angiotensinogen mRNA were detected easily in the liver biopsy specimens in all of the patients. Hepatic angiotensinogen mRNA levels were positively correlated with plasma angiotensinogen levels (r=0.41, P=0.013). In contrast, hepatic angiotensinogen mRNA levels did not show any significant relationship with plasma renin activity, plasma angiotensin II concentration, histological subgroup of hepatitis, histological activity index and parameters of liver function tests. The present study demonstrated, for the first time, that hepatic angiotensinogen mRNA levels correlated with plasma angiotensinogen concentration in humans.
authors.affiliation: Second Department of Internal Medicine, Yokohama City University School of Medicine, Kanazawa-Ku, Yokohama, Japan.
authors.forename: D
authors.initials: D
authors.lastname: Takahashi
authors.forename: K
authors.initials: K
authors.lastname: Tamura
authors.forename: T
authors.initials: T
authors.lastname: Ushikubo
authors.forename: A
authors.initials: A
authors.lastname: Moriya
authors.forename: N
authors.initials: N
authors.lastname: Yokoyama
authors.forename: N
authors.initials: N
authors.lastname: Nyui
authors.forename: E
authors.initials: E
authors.lastname: Chiba
authors.forename: K
authors.initials: K
authors.lastname: Hibi
authors.forename: T
authors.initials: T
authors.lastname: Ishigami
authors.forename: M
authors.initials: M
authors.lastname: Yabana
authors.forename: M
authors.initials: M
authors.lastname: Tomiyama
authors.forename: S
authors.initials: S
authors.lastname: Umemura
authors.forename: M
authors.initials: M
authors.lastname: Ishii
mesh_terms: D000328:Adult; D000368:Aged; D000808:Angiotensinogen / Q000097:blood* / Q000235:genetics*; D002908:Chronic Disease; D005260:Female; D006505:Hepatitis / Q000097:blood / Q000378:metabolism*; D006801:Humans; D008099:Liver / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D012333:RNA, Messenger / Q000378:metabolism*; D012084:Renin-Angiotensin System / Q000502:physiology; D012709:Serum Albumin / Q000378:metabolism
chemical_list: D012333:RNA, Messenger; D012709:Serum Albumin; D000808:Angiotensinogen